Qifu Technology's Paper Accepted by IJCAI 2025, Using MLLM to Pave New Path in Fintech
SHANGHAI, May 7, 2025 /PRNewswire/ -- China's leading fintech company Qifu Technology ( NASDAQ: QFIN; HKEX: 3660) and Beijing Jiaotong University have jointly achieved a significant milestone as their paper, Leveraging MLLM Embeddings and Attribute...
TPIsoftware's digiRunner Wins Vietnam Sao Khue Awards 2025 for Retail Ecosystem Innovation
TAIPEI, April 29, 2025 /PRNewswire/ -- TPIsoftware (TWSE: 7781), Taiwan's leading software company specializing in digital transformation, has been awarded the Sao Khue Awards 2025 in recognition of its API management platform digiRunner's proven...
Caliway's CBL-514 Phase 2 Study (CBL-0202) Accepted for Publication in the Aesthetic Surgery Journal
Advancing Scientific Recognition in Non-Surgical Fat Reduction Caliway's CBL-514 Phase 2 study (CBL-0202) has been accepted for publication in Aesthetic Surgery Journal (ASJ), the top-ranked journal in aesthetic medicine and plastic surgery....
Winners Announced in 19th Annual Stevie® Awards for Sales & Customer Service
World's Top Customer Service and Sales Awards Winners to be Honored at Ceremony in New York City FAIRFAX, Va., March 6, 2025 /PRNewswire/ -- Winners in the 19th annual Stevie® Awards for Sales & Customer Service, recognized as the world's top...
WUSD Now Accepted at Iconic Metro Department Store Through dtcpay Integration
SINGAPORE, Feb. 28, 2025 /PRNewswire/ -- Worldwide Stablecoin Payment Network (WSPN) is pleased to announce that its flagship stablecoin, WUSD, is now accepted at Metro Department Store through dtcpay's innovative payment solution. This development...
IASO Bio Announces Acceptance of New Drug Application for Equecabtagene Autoleucel (FUCASO) by the Hong Kong Department of Health
SHANGHAI and NANJING, China and SAN JOSE, Calif., Feb. 14, 2025 /PRNewswire/ -- IASO Biotherapeutics ("IASO Bio"), a biopharmaceutical company focused on the discovery, development, manufacturing, and commercialization of innovative cell therapies...
Akeso's Gumokimab Monoclonal Antibody (IL-17) New Drug Application for the Treatment of Moderate to Severe Psoriasis Accepted by NMPA
HONG KONG, Jan. 27, 2025 /PRNewswire/ -- Akeso, Inc. (9926.HK) ("Akeso" or the "Company") is pleased to announce that the New Drug Application (NDA) of its internally-developed IL-17-targeting monoclonal antibody gumokimab (AK111) has been accepted...
Shining at CES 2025, TCL Garners Multiple Awards for Display Innovations and Smart Home Solutions
LAS VEGAS, Jan. 15, 2025 /PRNewswire/ -- TCL Electronics, a leading consumer electronics brand and the world's top two TV brand, has been honored with multiple awards at CES 2025, demonstrating its technological excellence in display innovations and...
ATFX Connect Won Best B2B Liquidity Provider (Prime of Prime) at Finance Magnates London Summit 2024
HONG KONG, Dec. 3, 2024 /PRNewswire/ -- ATFX Connect, the institutional arm of global trading platform ATFX, has been named Best B2B Liquidity Provider (Prime of Prime) at the 2024 Finance Magnates London Summit (FMLS). The award acknowledges the...
Infineon wins German Sustainability Award 2025
– Infineon wins prestigious award in the category "Electrical Engineering and Electronics". – The company makes significant progress in implementing its ambitious sustainability strategy. – German Sustainability Award is Europe's largest award for...